MEET OUR TEAM

• Go-To-Market
• Strategy + Capital

The problem I solve

I help founders build the team, business model, and go-to-market engine that turns 'we need funding' into 'we're worth more than we thought.' We often end up fixing adjacent problems before tackling the one they came in with, and the outcome ends up better than expected (raising $5M instead of $2M, for example).

What I've done

I launched Amazon Fresh in 10 different countries and launched a consumer brand, Bunafr, in one of the most crowded spaces with a unique value proposition, winning several awards along the way. I have built a unique business model in the one of the most complicated industries and pivoted a couple of times. I have strengths on how to attract the right talent which every founder need to learn, and finally lessons on what happens when executed with exit strategy in mind vs not. My background spans Amazon, Qualcomm, Coca-Cola, and Amdocs.

What working with me looks like

It's a combination of structured and as-needed. We set clear objectives together, but things come up along the way and we stay connected as needed. You get clarity on how to build your business — a growth plan covering hiring, fundraising, and strategic partnerships — built with an exit strategy in mind from the start.

How fast you'll see results

Most founders see clarity within 2-3 months.

Office Hours

1 hour, once a month

• Strategy + Capital

The problem I solve

I help founders raise money, model their business, and position it for the next stage of growth. Founders come to me saying "we need an AI agent," but usually the real problem is a messy workflow, disconnected data, or an unclear customer need. I fix that first, then build the smallest useful system that actually proves the value.

What I've done

I founded ForwardLane and took it from early AI prototypes to production distribution intelligence used by Invesco, converting enterprise pilots into long-term commercial deployments. Before that I authored the Johannesburg Stock Exchange's five-year technology transformation strategy, and co-founded HotelsByDay, scaling it to 450 hotels across 45+ cities. These days I’m building Hypebase and Signal Studio, and run SignalHaus.ai for hands-on AI strategy work with mid-market and enterprise clients. Built ForwardLane into a production enterprise AI platform used by Invesco, with long-term commercial deployments in financial services. Selected for Barclays Techstars London, one of 10 companies from 685 applicants, and the FinTech Innovation Lab New York. Secured strategic investment in ForwardLane from investors including Thomson Reuters, SEI Ventures and SixThirty. Co-founded HotelsByDay and helped grow the platform to 450 hotels across 45+ cities; filed a patent for its intra-day reservation system. Featured speaker on AI in wealth and asset management at MIT, Yale and the World Economic Forum.

What working with me looks like

We meet through weekly structured check-ins. You leave with a prioritized use case, a clear build-versus-buy call, and a delivery plan tied to real business metrics. On execution engagements I own a defined piece of work, an AI prototype, a data-integration design, a workflow automation, with a handoff your team can actually use. The goal is less wasted build effort, not another strategy deck.

How fast you'll see results

Within the first 1-2 weeks we usually land on a scoped problem, success metrics, and next steps. A tightly scoped prototype or automation can often be targeted within 2-4 weeks once data and access are in place.

• Protection + Compliance
• Strategy + Capital

The problem I solve

A unique and compelling clinical development plan for a biotech startup that asks how to attract investors and project sales.

What I've done

I am a physician and pharmaceutical executive with 25 years of experience in clinical development, drug approvals, and biotech leadership. I serve as Founder and CEO of 4M Therapeutics, and previously served as Chief Medical Officer at Lexicon Pharmaceuticals and Vice President of Clinical Development at Bristol-Myers Squibb. My clinical research spans oncology, immunology, gastroenterology, cardiology, endocrinology, and ophthalmology, and my work has been published in over 100 journal articles, including the New England Journal of Medicine. I led clinical development for the successful FDA and EMA approvals of Avalide, Xermelo, and Zynquista, including key regulatory meetings and FDA Advisory Committee presentations. As founder of 4M Therapeutics, I raised over $10 million in seed funding and advanced a novel compound to clinical-trial readiness. My experience also includes leading epidemiology and outcomes research teams, where I supported pricing and reimbursement for 10 major products, including Plavix, Opdivo, and Eliquis. I helped secure FDA breakthrough designation for a new medicine, and I have been involved in the design and oversight of 10 successful Phase 3 clinical trials.

What working with me looks like

I help founders develop clinical development strategies that make their science investable. We meet through weekly structured check-ins, working toward a differentiated go-to-market strategy built on a solid, defensible clinical plan.

How fast you'll see results

Founders typically see progress on a differentiated go-to-market strategy within one month.

• Strategy + Capital

The problem I solve

I help founders quantify their strategy, so they can make better decisions and raise capital with a model that actually holds up.

What I've done

I am recognized as a top 10 worldwide financial modeler who's also built, acquired, and exited two companies. I owned and operated Redbooks and co-founded Robuzz. Ranked #9 worldwide in the Financial Modeling World Cup and authored 3 cases used in global competition Acquired and sold Redbooks (SaaS) to List Partners, a Northland Capital portfolio company; co-founded and sold Robuzz (ML/NLP) to Aidentified. Unblocked a stalled M&A close by resolving a cap table issue the internal team couldn't solve — the deal closed

What working with me looks like

Founders come thinking they need a better financial model. What they need is a sharper strategy — the model is just where the weak spots show up first. We connect as-needed via email or Slack, and you walk away with a working model you can update yourself, pressure-test decisions with, and put in front of investors without flinching.

How fast you'll see results

A working model is typically in place within 1-2 weeks, ready for board or investor conversations within 30 days. Discrete deliverables like cap table cleanup often take days, not weeks.

• Strategy + Capital

The problem I solve

Accessing funding from the government requires building real relationships and champions inside agencies and on the Hill — not just filling out an application.

What I've done

I am the Founder of G2G Consulting, which I started in 2007 to help startups, businesses, and nonprofits create and execute Government-to-Growth strategies. I previously served as Legislative Director for two Members of Congress in Washington, D.C., and as a Policy Analyst for the UK Parliament's Health Committee. Secured $624M in non-dilutive government funding for health and high-tech innovation clients Raised $89M, $10M, and $12M respectively for clients including SHEPHERD Therapeutics, Voltron, and TEGA Built a bipartisan team that has shaped policy, drafted legislation, and organized advocacy campaigns across the health and innovation sectors

What working with me looks like

We connect as needed via email or Slack. I help founders access government funding by building the relationships and champions that make it possible — not just navigating paperwork.

How fast you'll see results

Most founders see progress in securing new relationships and funding within a few months.

Office Hours

1 hour, once a month

• Strategy + Capital

The problem I solve

I help founders define their AI strategy and capabilities, so their product decisions and positioning are grounded in what the technology can actually do.

What I've done

I am the Head of Data & Analytics Enablement at Chubb, where I lead teams that embed data assets and AI/GenAI capabilities across the business — including pricing sophistication, automation, data enrichment, segmentation, and claims management. I previously held leadership roles spanning strategy, digital, technology, and operations, transforming digital journeys and platforms for brokers and clients with 2X+ adoption and NPS increases. Led AI/GenAI capability build-out across pricing, automation, and claims for a major global insurer Managed technology M&A for two large insurance carriers, overseeing $50M+ in annual budgets Doubled digital adoption and NPS through platform transformations for brokers and clients

What working with me looks like

We meet through weekly structured check-ins. This is hands-on, experience-based guidance and I help you get clear on your AI strategy and capabilities so your product decisions and positioning hold up.

How fast you'll see results

Most founders see clarity on product decisions and positioning within a month.

Office Hours

1 hour, once a month

• Strategy + Capital

The problem I solve

If early-stage companies want to raise venture money, what they're really looking for are angel investors — I help founders see that distinction and focus their fundraising strategy accordingly.

What I've done

I bring comprehensive international experience across Pharma, Biotech, and VC. I previously served in Business Development at Novartis and as International Business Leader at Roche, and I am now a Venture Partner at RA Capital. Raised $50M+ in venture capital and manages a VC fund, having doubled AUM and the number of investments since joining three years ago Led 100+ transactions with a total value of $2B+ Launched 6 drugs across oncology and immunology (orphan) indications; currently serves as Director on 2 boards (10 others historically) with 6 observer seats

What working with me looks like

I provide founders with financing contacts and advice on strategy, focus, execution, and, for biotech, the disease area itself. We meet through weekly structured check-ins, with a focus on sharpening competitive positioning.

How fast you'll see results

Most founders see progress within a month.

Office Hours

1 hour, once a month

• Go-To-Market
• Strategy + Capital

“I have over 20 years of experience managing end to end operations internationally, plus successfully deploying transformation and leading change for large corporations and scaling businesses.”

The problem I solve

I help founders build an operating model design that balances service, cost and cash for scale, focusing on agility and resilience.

What I've done

I have over 20 years of experience managing end-to-end operations internationally, plus a track record deploying transformation and leading change for large corporations and scaling businesses. I currently serve as VP Operations EMEA at Deckers Brands. Previously, I've worked as Northern Europe Supply Chain Director at General Mills, and IBP and Distribution Global Director at Nomad Foods. I led business transformation balancing cost, service, and cash — delivering annual savings of over 5% while reducing inventory levels and adopting new technology Conceptualized and deployed new operating models for new brands, scaling businesses, and new trading territories, including infrastructure integration and change management through M&A Delivered innovation, distribution automation, and sustainability roadmaps supporting businesses in achieving Science Based Targets. - Helped 10 DTC brands scale e-commerce from $500K to $10M ARR - Raised $50M across Series A and B rounds; built financial models for SaaS and marketplace startups - Secured FDA clearance for three Class II medical devices

What working with me looks like

Founders walk away with a clear supply chain or operations strategy.

How fast you'll see results

Founders will start seeing results after a few sessions

Office Hours

1 hour, once a month